Wellness Clinical Research is recognizing two of its principal investigators, Lucky Flores, MD, and Gustavo Albizu-Angulo, MD, for their authorship on published Crohn’s disease research in Gastroenterology.
The abstract, “Efficacy of Ustekinumab in Crohn’s Disease With and Without Concurrent Autoimmune Skin Manifestation,” was published in 2020 and evaluated outcomes in Crohn’s disease in the presence or absence of concurrent autoimmune skin manifestations.
Published gastroenterology research
The publication examined the efficacy of ustekinumab in Crohn’s disease with and without concurrent autoimmune skin manifestations. It was published as a Gastroenterology abstract in 2020.
Both Dr. Flores and Dr. Albizu-Angulo appear in the author list, documenting their contribution to the published work.
WCR investigator experience in inflammatory bowel disease
The publication adds to the documented inflammatory bowel disease research experience of investigators working across Wellness Clinical Research’s Florida and Puerto Rico locations.
WCR continues to support sponsor and CRO programs across gastroenterology, including Crohn’s disease and ulcerative colitis.